PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Forty-three percent of melanoma patients have chronic complications from immunotherapies

2021-03-25
(Press-News.org) Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.

The chronic complications, which occurred in 43% of patients, affected the joints and endocrine system most commonly, and less often involved salivary glands, eyes, peripheral nerves and other organs. These complications may be long lasting, with only 14% of cases having been resolved at last follow-up. This finding contrasted with previously reported immunotherapy-related acute complications that affected visceral organs -- including the liver, colon, lungs and kidneys -- which were effectively treated with steroids. However, the vast majority of chronic complications were not severe or life threatening.

"Chronic and long-lasting side effects were more common than we expected and involved a variety of often overlooked organs like the thyroid, salivary glands and joints," said the study's senior author, Douglas Johnson, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center and clinical director of Melanoma at Vanderbilt-Ingram Cancer Center.

The retrospective study reviewed the incidence and spectrum of chronic immune-related adverse events in melanoma patients who were treated with adjuvant anti-PD-1 immunotherapies (pembrolizumab or nivolumab) at eight academic medical centers between 2015 and 2020. Chronic complications were defined as those persisting at least 12 weeks after immunotherapy treatments had ended. The study is the first to systematically examine anti-PD-1-related chronic complications in patients with high-risk, resected melanoma.

Most of the chronic complications (96%) were grade 1 or 2 events with no or mild symptoms. The more common complications included adrenal insufficiency, arthritis, dermatitis and thyroiditis.

Rare and acute immune-related adverse events that occur early in the course of treatment with the immunotherapy, such as cardiovascular complications, can be more serious. Johnson and colleagues at Vanderbilt-Ingram first reported in 2016 rare but fatal cardiac side effects from immunotherapies.

"While these side effects are important to monitor and treat, anti-PD-1 therapies remain life saving for many patients with melanoma" Johnson said.

INFORMATION:

The study's lead author is J. Randall Patrinely, Jr., BA. Other contributing authors from Vanderbilt included Fei Ye, PhD; Ran Fan, PhD and Elizabeth Davis, MD.



ELSE PRESS RELEASES FROM THIS DATE:

Moderate daily caffeine intake during pregnancy may lead to smaller birth size

2021-03-25
Pregnant women who consumed the caffeine equivalent of as little as half a cup of coffee a day on average had slightly smaller babies than pregnant women who did not consume caffeinated beverages, according to a study by researchers at the National Institutes of Health. The researchers found corresponding reductions in size and lean body mass for infants whose mothers consumed below the 200 milligrams of caffeine per day--about two cups of coffee--believed to increase risks to the fetus. Smaller birth size can place infants at higher risk of obesity, heart ...

The CNIO describe how embryonic stem cells keep optimal conditions for use in regenerative medicine

The CNIO describe how embryonic stem cells keep optimal conditions for use in regenerative medicine
2021-03-25
Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muñoz, have described the mechanisms, unknown to date, involved in maintaining embryonic stem cells in the best possible state for their use in regenerative medicine. Their results, published in Nature Communications, will help to find novel stem-cell therapies for brain stroke, heart disease or neurodegenerative conditions like Alzheimer's or Parkinson's disease. Naïve pluripotent stem cells, ideal for doing research Embryonic stem cells (ESCs) are pluripotent cells that can grow ...

Detecting hidden signals

2021-03-25
Quantum holds the promise of increasing the power of sensing technologies. While the field of quantum sensing has shown a lot of potential for detecting very small signals, the ability to truly optimize these sensors has been thwarted by the complexity of control schemes. In a paper published on March 25 in Nature Partner Journals - Quantum Information, a research team based at the Johns Hopkins University Applied Physics Laboratory (APL) in Laurel, Maryland, explained how they applied two theoretical tools of quantum information to these types of extremely sensitive signal detection tasks. Their research suggests that honing this sensitivity to detect signals while rejecting background noise will enable the use of quantum ...

Does selfishness evolve? Ask a cannibal

Does selfishness evolve? Ask a cannibal
2021-03-25
HOUSTON - (March 25, 2021) - One of nature's most prolific cannibals could be hiding in your pantry, and biologists have used it to show how social structure affects the evolution of selfish behavior. Researchers revealed that less selfish behavior evolved under living conditions that forced individuals to interact more frequently with siblings. While the finding was verified with insect experiments, Rice University biologist Volker Rudolf said the evolutionary principal could be applied to study any species, including humans. In a study published online this week in Ecology Letters, Rudolf, longtime collaborator Mike Boots of the University of California, Berkeley, and colleagues showed they could drive the evolution of cannibalism in ...

Global evidence for how EdTech can support pupils with disabilities is 'thinly spread'

2021-03-25
An 'astonishing' deficit of data about how the global boom in educational technology could help pupils with disabilities in low and middle-income countries has been highlighted in a new report. Despite widespread optimism that educational technology, or 'EdTech', can help to level the playing field for young people with disabilities, the study found a significant shortage of evidence about which innovations are best-positioned to help which children, and why; specifically in low-income contexts. The review also found that many teachers lack training on how to use new technology, or are reluctant to do so. The ...

Should you take fish oil? Depends on your genotype

2021-03-25
Fish oil supplements are a billion-dollar industry built on a foundation of purported, but not proven, health benefits. Now, new research from a team led by a University of Georgia scientist indicates that taking fish oil only provides health benefits if you have the right genetic makeup. The study, led by Kaixiong Ye and published in PLOS Genetics, focused on fish oil (and the omega-3 fatty acids it contains) and its effect on triglycerides, a type of fat in the blood and a biomarker for cardiovascular disease. "We've known for a few decades that a higher level of omega-3 fatty acids in the blood is associated with a lower risk of heart disease," said Ye, assistant professor ...

Common Alzheimer's treatment linked to slower cognitive decline

2021-03-25
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer's disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study involving researchers from Karolinska Institutet in Sweden and published in the journal Neurology shows persisting cognitive benefits and reduced mortality for up to five years after diagnosis. Alzheimer's disease is a cognitive brain disease that affects millions of patients around the world. Some 100,000 people in Sweden live with the diagnosis, which has a profound impact on the lives of both them and their families. Most of those who receive a diagnosis are over 65, but there are some patients ...

Will COVID-19 vaccines need to be adapted regularly?

Will COVID-19 vaccines need to be adapted regularly?
2021-03-25
Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent this may be necessary, a team of researchers from Charité - Universitätsmedizin Berlin compared the evolution of endemic 'common cold' coronaviruses with that of influenza viruses. The researchers predict that, while the pandemic is ongoing, vaccines will need to undergo regular updates. A few years into the post-pandemic period, however, vaccines ...

Women accumulate Alzheimer's-related protein faster

2021-03-25
Alzheimer's disease seems to progress faster in women than in men. The protein tau accumulates at a higher rate in women, according to research from Lund University in Sweden. The study was recently published in Brain. Over 30 million people suffer from Alzheimer's disease worldwide, making it the most common form of dementia. Tau and beta-amyloid are two proteins known to aggregate and accumulate in the brain in patients with Alzheimer's. The first protein to aggregate in Alzheimer's is beta-amyloid. Men and women are equally affected by the first disease stages, and the analysis did not show any differences in the accumulation of ...

Massive study reveals few differences between men and women's brains

2021-03-25
How different are men and women's brains? The question has been explored for decades, but a new study led by Rosalind Franklin University neuroscientist END ...

LAST 30 PRESS RELEASES:

New breakthrough method to protect quantum spins from noise

Chemicals from turmeric and rhubarb could help fight antibiotic-resistant bacteria lurking in wastewater

Instant cancer diagnosis with light and AI!

New electroenzymatic strategy enables non-natural oxidation reactions

Tunable laser light

Scientists uncover magnetic-field control of ultrafast spin dynamics in 2D ferromagnets

New AI-powered model accurately predicts lung motion with minimal radiation

AI language models show promise in predicting liver cancer treatment outcomes

Tracking insect and bug health in a heartbeat from a digital camera

'Talking fish' not heard by conservation policies, SFU study warns

Thirty years of research shows increased resistance in fungi

Junk food ‘avoids advertising regulation’ with top level UK sports sponsorship

Banking on AI while committed to net zero is ‘magical thinking’, claims report on energy costs of big tech

Ancient river systems reveal Mars was wetter than we thought

Online toolkit to help parents of autistic children improve dental health

The psychological and neurological parallels between sports fandom and religious devotion

Agricultural liming in the US is a large CO2 sink, say researchers

Seaside more likely to make us nostalgic than green places, study finds

Psilocybin delays aging, extends lifespan, Emory study suggests

Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform

Orange is the new aphrodisiac—for guppies

Murals boost Cincinnati’s vitality, community development

Ad blockers may be showing users more problematic ads, NYU Tandon study finds

Verbal response time reveals hidden sleepiness in older adults

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

[Press-News.org] Forty-three percent of melanoma patients have chronic complications from immunotherapies